Searched for
ALLERGAN SALES LLC
Alembic Pharma gets USFDA nod for generic hypertension treatment capsulesAlembic Pharmaceuticals has received USFDA final approval for its generic Diltiazem Hydrochloride extended-release capsules in strengths of...- Lupin launches generic contraceptive drug in USDrug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market. The Mumbai-bas...
- Market movers: Eureka Forbes launches open offer at 58% discount; stocks tanks 5%Last year in September, Advent International acquired a majority stake in Eureka Forbes, the consumer durables flagship company of Shapoorj...
- Alembic Pharma gets USFDA nod for bipolar disorder treatment drugIn a regulatory filing, Alembic Pharmaceuticals said it has received approval from the US Food and Drug Administration (USFDA) for its abbr...
- Strides Pharma gets USFDA nod for Ursodiol tablets, a liver disease treatment drugStrides Pharma Science gets an approval from the USFDA to market Ursodiol tablets used for treating primary biliary cirrhosis, a progressiv...
- Alembic gets USFDA nod for Silodosin capsulesAlembic Pharmaceuticals on Tuesday said it has received final approval from the US health regulator for its generic Silodosin capsules used...
- Lupin launches pain relieving generic tablets in USLupin's product is a generic version of Allergan Sales LLC's Norco tablets in the same strengths and is indicated for relief of moderate to...
- Lupin gets USFDA's final nod for pain relief tabletsThe tablets are generic version of Allergan Sales LLC's Norco tablets in the same strengths and the product will be launched shortly, Lupin...
- Cipla divests 16.7 per cent stake in Chase Pharma to AllerganChase was recently financed by a Series B consortium consisting of New Rhein Healthcare, Edmond de Rothschild Investment Partners and Cipla...
- Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offersIf successful, this would be Aurobindo's largest ever acquisition, surpassing its $132.5 mn purchase of US vitamin maker Natrol Inc in 2014.
- Brent Saunders gets key job as Pfizer, Allergan combineSaunders, 45, an intrepid deal maker, has a history of eventually leading companies that he had helped combine.
- Indian companies among firms yet to pay annual facility fees to FDAFDA has named at least five Indian companies among 43 drugmakers that have failed to meet their annual facility fee payment obligations.
Load More
